Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Quotient Limited Ord (QTNT)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 533,254
  • Shares Outstanding, K 65,031
  • Annual Sales, $ 24,730 K
  • Annual Income, $ -82,340 K
  • 60-Month Beta 1.32
  • Price/Sales 15.20
  • Price/Cash Flow N/A
  • Price/Book 18.43

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/19
See More
  • Average Estimate -0.44
  • Number of Estimates 1
  • High Estimate -0.44
  • Low Estimate -0.44
  • Prior Year -0.44
  • Growth Rate Est. (year over year) unch

Price Performance

See More
Period Period Low Period High Performance
1-Month
8.00 +2.50%
on 04/17/19
9.55 -14.09%
on 03/19/19
-1.22 (-12.95%)
since 03/18/19
3-Month
7.18 +14.21%
on 01/22/19
11.15 -26.46%
on 03/04/19
+0.78 (+10.51%)
since 01/18/19
52-Week
3.69 +122.22%
on 04/24/18
11.15 -26.46%
on 03/04/19
+3.40 (+70.83%)
since 04/18/18

Most Recent Stories

More News
Quotient Limited to Participate in the Cowen and Company 39th Annual Health Care Conference

Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that the Company's Chief Financial Officer, Chris Lindop, will present at the Cowen and Company 39 Annual Health...

QTNT : 8.20 (-1.91%)
Quotient Limited to Host Investor Day and Ring Closing Bell at the NASDAQ on March 4, 2019

Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that the Company will host an Investor Day on Monday, March 4, 2019 from 1:00pm - 3:00pm ET, in New York, NY. Following...

QTNT : 8.20 (-1.91%)
Quotient Limited to Participate in the 8th Annual SVB Leerink Global Healthcare Conference

Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that today announced that the Company's Chief Executive Officer, Franz Walt, will present at the 8 Annual SVB Leerink...

QTNT : 8.20 (-1.91%)
Quotient (QTNT) Reports Q3 Loss, Tops Revenue Estimates

Quotient (QTNT) delivered earnings and revenue surprises of -12.20% and 8.44%, respectively, for the quarter ended December 2018. Do the numbers hold clues to what lies ahead for the stock?

QTNT : 8.20 (-1.91%)
Quotient Limited Provides an Update on Extended Immunohematology Microarray Performance and on the Commencement of the Initial Serological Disease Screening Field Trial together with Third Quarter Fiscal 2019 Results

-- Development data provides positive results for extended IH microarray panel

QTNT : 8.20 (-1.91%)
Quotient Limited to Report Fiscal Third Quarter 2019 Financial Results and Host Conference Call

Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that financial results for its fiscal third quarter ended December 31, 2018, will be released before market open...

QTNT : 8.20 (-1.91%)
Quotient Limited to Report Fourth Quarter and Fiscal Full Year 2018 Financial Results and Host Conference Call

Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that financial results for its fourth quarter and fiscal full year ended March 31, 2018, will be released before...

QTNT : 8.20 (-1.91%)
Quotient Limited Announces FDA Approval of Seven Blood Bank Reagents, Including Two Market Firsts

Quotient Limited ("Quotient") (NASDAQ: QTNT), an established, commercial-stage diagnostics company, today announced the recent FDA approval for U.S. commercialization of seven new blood bank reagents including...

QTNT : 8.20 (-1.91%)
Pre-Market Technical Scan on Healthcare Equities -- Atossa Genetics, Palatin Technologies, Quotient, and Avadel Pharma

WallStEquities.com strives to bring the best free research to the investment community. Today we are offering reports on ATOS, PTN, QTNT, and AVDL which can be accessed for free by signing up to www.wallstequities.com/registration....

AVDL : 1.15 (-1.71%)
ATOS : 2.54 (-3.05%)
PTN : 1.06 (-2.75%)
QTNT : 8.20 (-1.91%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators mostly agree with the trend.

See More Share

Trade QTNT with:

Business Summary

Quotient Limited is a commercial-stage transfusion diagnostics company. It is focused on supplying blood-grouping consumables and developing MosaiQ, a fully automated platform for use in donor centers and patient-testing sites. Quotient Limited is headquartered in Edinburgh, Scotland and Newton, Pennsylvania....

See More

Key Turning Points

2nd Resistance Point 8.92
1st Resistance Point 8.56
Last Price 8.20
1st Support Level 7.95
2nd Support Level 7.70

See More

52-Week High 11.15
Fibonacci 61.8% 8.30
Last Price 8.20
Fibonacci 50% 7.42
Fibonacci 38.2% 6.54
52-Week Low 3.69

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar